Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-13445-2
PubMed Identifier: 31797922
Publication URI: http://europepmc.org/abstract/MED/31797922
Type: Journal Article/Review
Parent Publication: Nature Communications
Issue: 1
ISSN: 2041-1723